Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Chiarle

Showing results (31-40 of 156) with videos related to

Pageof 16
Sort By:
Science Translational Medicine|December 14, 2018
Comment on "ALK is a therapeutic target for lethal sepsis"Rafael B Blasco, Enrico Patrucco, Ines Mota, et al.
Cytometry. Part B, Clinical Cytometry|January 18, 2013
Tissue flow cytometry immunophenotyping in the diagnosis and classification of non-Hodgkin's lymphomas: a retrospective evaluation of 1,792 casesAnna Demurtas, Alessandra Stacchini, Sabrina Aliberti, et al.
Journal of Forensic Sciences|January 21, 2006
Incestuous paternity detected by STR-typing of chorionic villi isolated from archival formalin-fixed paraffin-embedded abortion material using laser microdissectionCarlo Robino, Maria Rosa Barilaro, Sarah Gino, et al.
Technology in Cancer Research & Treatment|March 19, 2008
High energy shock waves (HESW) increase paclitaxel efficacy in a syngeneic model of breast cancerRoberto Canaparo, Loredana Serpe, Gian Paolo Zara, et al.
Blood|December 7, 2006
In the absence of IGF-1 signaling, IFN-gamma suppresses human malignant T-cell growthLaura Conti, Gabriella Regis, Angela Longo, et al.
Nature Medicine|May 13, 2008
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccinationRoberto Chiarle, Cinzia Martinengo, Cristina Mastini, et al.
Cancers|March 3, 2018
Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It GoesGeeta Geeta Sharma, Ines Mota, Luca Mologni, et al.
Cell Cycle (Georgetown, Tex.)|August 6, 2005
New and old functions of STAT3: a pivotal target for individualized treatment of cancerGiorgio Inghirami, Roberto Chiarle, William J Simmons, et al.
Blood|August 18, 2025
Epigenetic changes by EZH2 inhibition increase translocations in B cells with high AID activity or DNA repair deficiencyJianli Tao, Luca Alessandri, Alessandro Gasparetto, et al.
The Journal of Biological Chemistry|November 25, 2003
Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cellsStefano Buttiglieri, Maria Chiara Deregibus, Stefania Bravo, et al.
Pageof 16

Showing results (31-40 of 156) with videos related to

Sort By:
Pageof 16
Science Translational Medicine|December 14, 2018
Comment on "ALK is a therapeutic target for lethal sepsis"Rafael B Blasco, Enrico Patrucco, Ines Mota, et al.
Cytometry. Part B, Clinical Cytometry|January 18, 2013
Tissue flow cytometry immunophenotyping in the diagnosis and classification of non-Hodgkin's lymphomas: a retrospective evaluation of 1,792 casesAnna Demurtas, Alessandra Stacchini, Sabrina Aliberti, et al.
Journal of Forensic Sciences|January 21, 2006
Incestuous paternity detected by STR-typing of chorionic villi isolated from archival formalin-fixed paraffin-embedded abortion material using laser microdissectionCarlo Robino, Maria Rosa Barilaro, Sarah Gino, et al.
Technology in Cancer Research & Treatment|March 19, 2008
High energy shock waves (HESW) increase paclitaxel efficacy in a syngeneic model of breast cancerRoberto Canaparo, Loredana Serpe, Gian Paolo Zara, et al.
Blood|December 7, 2006
In the absence of IGF-1 signaling, IFN-gamma suppresses human malignant T-cell growthLaura Conti, Gabriella Regis, Angela Longo, et al.
Nature Medicine|May 13, 2008
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccinationRoberto Chiarle, Cinzia Martinengo, Cristina Mastini, et al.
Cancers|March 3, 2018
Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It GoesGeeta Geeta Sharma, Ines Mota, Luca Mologni, et al.
Cell Cycle (Georgetown, Tex.)|August 6, 2005
New and old functions of STAT3: a pivotal target for individualized treatment of cancerGiorgio Inghirami, Roberto Chiarle, William J Simmons, et al.
Blood|August 18, 2025
Epigenetic changes by EZH2 inhibition increase translocations in B cells with high AID activity or DNA repair deficiencyJianli Tao, Luca Alessandri, Alessandro Gasparetto, et al.
The Journal of Biological Chemistry|November 25, 2003
Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cellsStefano Buttiglieri, Maria Chiara Deregibus, Stefania Bravo, et al.
Pageof 16